Activating MET kinase rearrangements in melanoma and Spitz tumours
- PMID: 26013381
- PMCID: PMC4446791
- DOI: 10.1038/ncomms8174
Activating MET kinase rearrangements in melanoma and Spitz tumours
Abstract
Oncogenic gene fusions have been identified in many cancers and many serve as biomarkers or targets for therapy. Here we identify six different melanocytic tumours with genomic rearrangements of MET fusing the kinase domain of MET in-frame to six different N-terminal partners. These tumours lack activating mutations in other established melanoma oncogenes. We functionally characterize two of the identified fusion proteins (TRIM4-MET and ZKSCAN1-MET) and find that they constitutively activate the mitogen-activated protein kinase (MAPK), phosphoinositol-3 kinase (PI3K) and phospholipase C gamma 1 (PLCγ1) pathways. The MET inhibitors cabozantinib (FDA-approved for progressive medullary thyroid cancer) and PF-04217903 block their activity at nanomolar concentrations. MET fusion kinases thus provide a potential therapeutic target for a rare subset of melanoma for which currently no targeted therapeutic options currently exist.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4446791/bin/nihms-681531-f0001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4446791/bin/nihms-681531-f0002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4446791/bin/nihms-681531-f0003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4446791/bin/nihms-681531-f0004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4446791/bin/nihms-681531-f0005.gif)
Similar articles
-
NTRK3 kinase fusions in Spitz tumours.J Pathol. 2016 Nov;240(3):282-290. doi: 10.1002/path.4775. J Pathol. 2016. PMID: 27477320 Free PMC article.
-
BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.Br J Dermatol. 2009 Aug;161(2):364-72. doi: 10.1111/j.1365-2133.2009.09181.x. Epub 2009 Apr 29. Br J Dermatol. 2009. PMID: 19438459
-
Genetic similarities between Spitz nevus and Spitzoid melanoma in children.Cancer. 2004 Dec 1;101(11):2636-40. doi: 10.1002/cncr.20680. Cancer. 2004. PMID: 15503312
-
Genetic alterations in melanocytic tumors.J Dermatol Sci. 2006 Jul;43(1):1-10. doi: 10.1016/j.jdermsci.2006.05.002. J Dermatol Sci. 2006. PMID: 16750612 Review.
-
Understanding spitzoid tumours: new insights from molecular pathology.Br J Dermatol. 2008 Jan;158(1):4-14. doi: 10.1111/j.1365-2133.2007.08207.x. Epub 2007 Oct 4. Br J Dermatol. 2008. PMID: 17916202 Review.
Cited by
-
The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy.Pharmaceuticals (Basel). 2024 Mar 30;17(4):448. doi: 10.3390/ph17040448. Pharmaceuticals (Basel). 2024. PMID: 38675409 Free PMC article.
-
Spitz Melanocytic Tumors: A Fascinating 75-Year Journey.Genes (Basel). 2024 Jan 31;15(2):195. doi: 10.3390/genes15020195. Genes (Basel). 2024. PMID: 38397186 Free PMC article. Review.
-
Kinase Fusions in Spitz Melanocytic Tumors: The Past, the Present, and the Future.Dermatopathology (Basel). 2024 Feb 14;11(1):112-123. doi: 10.3390/dermatopathology11010010. Dermatopathology (Basel). 2024. PMID: 38390852 Free PMC article. Review.
-
Linking Gene Fusions to Bone Marrow Failure and Malignant Transformation in Dyskeratosis Congenita.Int J Mol Sci. 2024 Jan 28;25(3):1606. doi: 10.3390/ijms25031606. Int J Mol Sci. 2024. PMID: 38338888 Free PMC article.
-
Diagnosing Cutaneous Melanocytic Tumors in the Molecular Era: Updates and Review of Literature.Dermatopathology (Basel). 2024 Jan 18;11(1):26-51. doi: 10.3390/dermatopathology11010005. Dermatopathology (Basel). 2024. PMID: 38247727 Free PMC article. Review.
References
-
- Davies H, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954. - PubMed
-
- Pollock PM, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19–20. - PubMed
-
- Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2006;24:4340–4346. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- SRA/SRP033273
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous